BNP Paribas Financial Markets’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367 Hold
802
﹤0.01% 5568
2025
Q4
$1.76K Sell
802
-113
-12% -$182 ﹤0.01% 5359
2025
Q3
$1.46K Sell
915
-59
-6% -$77 ﹤0.01% 5196
2025
Q2
$1.58K Sell
974
-515
-35% -$832 ﹤0.01% 5096
2025
Q1
$1.77K Sell
1,489
-17,503
-92% -$27.9K ﹤0.01% 4999
2024
Q4
$39.1K Sell
18,992
-2,080
-10% -$4.84K ﹤0.01% 4524
2024
Q3
$53.3K Buy
21,072
+7,397
+54% +$24.1K ﹤0.01% 3604
2024
Q2
$58.4K Buy
+13,675
New +$88K ﹤0.01% 3410

Other funds holding GUTS

BNP Paribas Financial Markets's GUTS Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Fractyl Health (GUTS) position steady in Q1 2026 at 802 shares worth $367. The position accounts for ﹤0.01% of the portfolio, ranked #5568.

BNP Paribas Financial Markets first reported a position in GUTS in Q2 2024 and has held it in 8 quarters since. The position peaked at $58.4K in Q2 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • BNP Paribas Financial Markets held 802 shares of Fractyl Health worth $367 as of Q1 2026.
  • BNP Paribas Financial Markets left its Fractyl Health share count unchanged in Q1 2026.
  • Fractyl Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5568 holding.
  • BNP Paribas Financial Markets first reported a position in Fractyl Health in Q2 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Fractyl Health position peaked at $58.4K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.